Extending anti-clotting treatment after distal deep vein thrombosis could reduce further clot risk

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six.

A blood protein can reduce brain damage after a stroke

Every year, about 12 million people suffer from a stroke worldwide. A stroke occurs suddenly.

Large stroke trial finds intensive blood pressure lowering after clot removal worsens recovery

A large stroke trial has shown that intensive blood pressure lowering after clot removal worsens.

Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke

A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several.

Severe COVID-19 increases risk of life-threatening blood clots

Individuals hospitalized with severe COVID-19 are more likely to develop venous thromboembolism—a potentially life-threatening condition—than.

Gene variant influences risk for blood clots in COVID patients

A gene variant in the natural immune system influences the risk for blood clots in.

Gene variant influences risk for blood clots in COVID patients

A gene variant in the natural immune system influences the risk for blood clots in.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with.